Dermata Therapeutics, Inc (DRMA)
1.13
-0.02 (1.74%)
Upcoming Events
Latest Headlines
Dermata launches first Tome skincare product for consumers
August 25, 2026 8:31 AM - StreetInsider
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
August 25, 2026 8:31 AM - StreetInsider
Dermata opens preorders for Tome skincare product at $178
August 21, 2026 8:30 AM - StreetInsider
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
August 21, 2026 8:30 AM - StreetInsider
Form 4 Dermata Therapeutics, For: Aug 16 Filed by: PROEHL GERALD T
August 18, 2026 5:25 PM - SEC Filing
Form 4 Dermata Therapeutics, For: Aug 16 Filed by: Van Hoose Kyri K.
August 18, 2026 5:22 PM - SEC Filing
Form 25-NSE Dermata Therapeutics, Filed by: Nasdaq Stock Market LLC
August 17, 2026 4:23 PM - SEC Filing
Dermata Therapeutics raises $3.4M in private placement
August 17, 2026 8:31 AM - StreetInsider
Form 8-K Dermata Therapeutics, For: Aug 16
August 17, 2026 8:31 AM - SEC Filing
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 17, 2026 8:31 AM - StreetInsider
Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 19c
August 11, 2026 4:56 PM - StreetInsider
Form 10-Q Dermata Therapeutics, For: Jun 30
August 11, 2026 4:08 PM - SEC Filing
Form 8-K Dermata Therapeutics, For: Aug 11
August 11, 2026 4:07 PM - SEC Filing
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
August 11, 2026 4:06 PM - StreetInsider
Form 8-K Dermata Therapeutics, For: Aug 05
August 5, 2026 8:30 AM - SEC Filing
Dermata Therapeutics to launch first consumer skincare product Aug. 25
August 5, 2026 8:30 AM - StreetInsider
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
August 5, 2026 8:30 AM - StreetInsider
Full Article List